Cordycepin, derived from fungi, shows promise in cancer therapy by inhibiting growth factor signaling pathways critical for ...

High Investment and Government Initiatives to Boost Rare Diseases Treatment ModalitiesRockville, MD, Nov. 13, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive ...

KRRO-110 is designed to co-opt an endogenous enzyme, Adenosine Deaminase Acting on RNA’s (ADAR), to edit the “A” variant on SERPINA1 RNA, repair an amino acid codon, and restore secretion of normal ...

A new study has made significant strides in plant genome editing by developing an A-to-K base editing system for rice and ...

AX-0810 targeting NTCP for cholestatic diseases to be first ProQR Axiomer™ RNA editing program to enter the clinic Company to host virtual ...

One technique involves a group of enzymes called adenosine deaminase acting on RNA (ADAR). Adenosine is one of the building ...

撰文丨nagashi编辑丨王多鱼排版丨水成文CRISPR技术自问世以来，就表现出无可比拟的优势，并深刻改变了基因编辑领域乃至整个生命科学的研究模式。CRISPR技术脱胎于天然存在于细菌/古菌中的CRISPR防御系统，例如CRISPR-Cas9和CRI ...

AST-004 is a small-molecule adenosine A1/A3 receptor agonist that has exhibited significant cerebroprotective efficacy in preclinical models of acute ischemic stroke and traumatic brain injury. The ...

One way this occurs is by the work of enzymes that bind to RNA and switch one genetic letter for another. Those enzymes are named after what they do — adenosine deaminase that acts on RNA, or ADAR — ...

Nanomedicine. 2012;7(8):1253-1271. Although passive targeting approaches form the basis of clinical therapy, they suffer from several limitations. Ubiquitously targeting cells within a tumor is ...